Advancing pediatric respiratory health in Latin America, we raise awareness and provide support for rare lung diseases like Primary Ciliary Dyskinesia (PCD). Committed to early diagnosis, we strive to improve lives across borders.
The Rare Lung Diseases of Latin America Foundation, is where breath knows no borders. Our goal is to raise awareness and offer support to pediatric patients grappling with rare lung diseases throughout Latin America. With a special focus on Primary Ciliary Dyskinesia (PCD), a genetic disorder affecting the respiratory system, we embark on a journey of advocacy, education, and community outreach. Through these efforts, we aim to foster understanding, encourage early diagnosis, and uplift the lives of those navigating the complexities of PCD and other rare lung conditions in the Latin American region. Join us as we breathe beyond borders, promoting a future where every breath is one of hope and resilience.
Dr. Ricardo Mosquera
Inspired by my daughter born with Down syndrome, I've developed innovative approaches for caring for children with medical complexity, reducing fragmentation, improving outcomes, and lowering costs. Our program, serving as an enhanced medical home, provides world-class care for vulnerable children. Furthermore, I have pioneered different models of healthcare delivery, including establishing a multidisciplinary clinic for children with congenital diaphragmatic hernia, pulmonary hypertension, Primary Ciliary Dyskinesia, and, most recently, an outreach model of care for rare lung diseases in Mexico. Our programs functions as an enhanced medical home, delivering world-class care for the most fragile and vulnerable population of children, both medically and socially. Moving forward, our objective is to sustain this high degree of quality research and expand our program for Latin America.
Information coming soon
This program was launched with the recognition that Primary Ciliary Dyskinesia (PCD) is frequently underdiagnosed in Latin America due to limited awareness, scarce diagnostic resources, and the absence of established guidelines. Our initiative began with a pilot project across various Latin American countries, and it has now found full implementation exclusively in Mexico.
Our approach is patient-centric, involving engagement with local pulmonologists in Latin America. We deliver informative presentations at national conferences in their respective countries, sharing insights and resources to enhance PCD awareness and diagnosis. The PCD team provides direct contact information to local pulmonologists, fostering collaboration and resource accessibility. To further our commitment to comprehensive care, we offer an opportunity for Latin-American physicians to undergo specialized PCD training at our Houston center. In the past year alone, our center has received 120 referrals for PCD and is actively treating 65 patients diagnosed with the condition.
In Mexico, we provide hands-on training for local pulmonologists, equipping them with essential skills such as obtaining nasal ciliary biopsies, measuring nNO, utilizing HSVMA, and implementing airway clearance techniques. Additionally, we extend our support by assisting local physicians during telemedicine visits for their PCD patients, ensuring that patient care remains at the forefront of our mission
The graphic illustrating "Patients Referred from Different Regions of Mexico" serves as a visual representation of how broad our outreach program has been able to impact across Mexico. It highlights the geographic diversity and widespread reach of the program, showcasing that patients are coming from various regions across the country.
By visualizing the distribution of patient referrals, the graphic emphasizes the program's ability to extend its services to a wide and diverse population. It conveys that the impact is not confined to a specific locality but spans multiple regions, indicating a comprehensive and inclusive approach to healthcare outreach. . Our program, serves as an enhanced medical home, provides world-class care for vulnerable children. Furthermore, the program has pioneered different models of healthcare delivery, including establishing a multidisciplinary clinic for children with congenital diaphragmatic hernia, pulmonary hypertension, and Primary Ciliary Dyskinesia (PCD).
Information coming soon
Will update. Please hold! Information is currently being updated.
Primary Ciliary Dyskinesia (PCD) is a rare genetic disorder that affects the function of cilia, which are tiny hair-like structures in the respiratory tract, ears, and other parts of the body. These cilia play a crucial role in clearing mucus, bacteria, and debris from the airways.
Key Features of PCD:
Management and Treatment:
While there is no cure for PCD, management involves addressing symptoms and complications. Treatment may include:
Importance of Early Diagnosis:
Early diagnosis of PCD is crucial for better management and improved quality of life. It allows for the initiation of appropriate interventions to address respiratory symptoms and prevent complications.
A multidisciplinary approach involving pediatric pulmonologists, otolaryngologists, and other specialists is often necessary to provide comprehensive care for children with PCD. Genetic counseling may also be recommended for families affected by this rare genetic condition.
We are currently working on updating our patient stories section. Please check back soon for updates.
Copyright © 2024 Breath Beyond Borders - All Rights Reserved.
Powered by GoDaddy
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.